Evaluation of an alternative extended-infusion piperacillin–tazobactam dosing strategy for the treatment of gram-negative infections
Crossref DOI link: https://doi.org/10.1007/s11096-016-0334-1
Published Online: 2016-06-22
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Winstead, Erin M.
Ratliff, Patrick D.
Hickson, Ryan P.
Mueller, Joseph E.
Judd, William R.
License valid from 2016-06-22